Naltrexone: A Clinically Proven Aid for Alcohol Cessation
| Product dosage: 50mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $7.14 | $214.31 (0%) | 🛒 Add to cart |
| 60 | $6.76 | $428.62 $405.59 (5%) | 🛒 Add to cart |
| 90 | $6.62
Best per pill | $642.94 $595.87 (7%) | 🛒 Add to cart |
Synonyms | |||
Naltrexone is a prescription medication approved by the FDA for the treatment of alcohol use disorder (AUD). It functions as an opioid receptor antagonist, working to reduce the craving for alcohol and diminish the pleasurable effects associated with its consumption. By targeting the brain’s reward pathways, naltrexone helps break the cycle of reinforcement that sustains alcohol dependence. This medication is a cornerstone of a comprehensive treatment plan, which should include counseling and behavioral therapies for optimal outcomes. It is intended for use in patients who have undergone medical detoxification and are committed to maintaining abstinence.
Features
- Active ingredient: Naltrexone Hydrochloride
- Available in 50 mg oral tablets and extended-release injectable formulations
- FDA-approved for the treatment of alcohol dependence
- Non-addictive and does not cause physical dependence
- Typically prescribed as part of a comprehensive treatment plan
- Can be used in conjunction with psychosocial support and counseling
Benefits
- Significantly reduces the urge to consume alcohol, aiding in the maintenance of abstinence.
- Diminishes the rewarding and euphoric effects of alcohol if consumed, reducing the incentive to drink.
- Supports long-term recovery by helping to rewire the brain’s response to alcohol over time.
- Non-habit forming, with no risk of developing a new substance dependence.
- Allows patients to focus more effectively on behavioral therapies and lifestyle changes.
- Can be used safely in an outpatient setting under proper medical supervision.
Common use
Naltrexone is prescribed for adults diagnosed with alcohol use disorder who are motivated to reduce their alcohol intake or achieve abstinence. It is typically initiated after the patient has successfully completed alcohol detoxification and is no longer physically dependent on alcohol. The medication is used as one component of a multifaceted treatment approach that includes medical supervision, counseling, and participation in support groups. It is suitable for both individuals new to treatment and those who have experienced relapse in the past.
Dosage and direction
The standard dosage for naltrexone oral tablets is 50 mg once daily, though some patients may be started on a lower dose to assess tolerance. It can be taken with or without food. The extended-release injectable formulation is administered as a 380 mg intramuscular gluteal injection once every four weeks by a healthcare professional. It is crucial to follow the prescribing physician’s instructions precisely. Treatment duration is individualized but often continues for several months to a year or longer, depending on patient progress and clinical assessment. Never adjust the dosage without consulting your doctor.
Precautions
Before starting naltrexone, inform your healthcare provider of any history of liver disease, kidney impairment, or depression. Patients should be opioid-free for a minimum of 7-10 days prior to initiation to avoid precipitating acute withdrawal. Use with caution in individuals with coagulation disorders or thrombocytopenia, particularly with the injectable form. Naltrexone may cause dizziness or drowsiness; avoid driving or operating heavy machinery until you know how the medication affects you. Regular liver function tests are recommended during treatment. It is not recommended for use during acute alcohol withdrawal.
Contraindications
Naltrexone is contraindicated in patients who are currently dependent on opioids or are in acute opioid withdrawal. It must not be used in individuals who have failed the naloxone challenge test or have a history of hypersensitivity to naltrexone or any component of the formulation. It is also contraindicated in patients with acute hepatitis or liver failure. The injectable form is contraindicated in patients with thrombocytopenia or any coagulation disorder that would contraindicate intramuscular injection.
Possible side effects
Common side effects may include nausea (which often subsides with continued use), headache, dizziness, nervousness, insomnia, and fatigue. Some patients may experience abdominal cramps, joint or muscle pain, or decreased energy. Less frequently, anxiety, vomiting, or loss of appetite may occur. The injectable formulation can cause injection site reactions, including pain, tenderness, induration, swelling, or bruising. Although rare, serious side effects can include hepatotoxicity, depression, or suicidal ideation. Report any severe or persistent symptoms to your healthcare provider immediately.
Drug interaction
Naltrexone may interact with opioid-containing medications, including some cough suppressants and antidiarrheal agents, potentially blocking their effects and precipitating withdrawal in dependent individuals. Concurrent use with other hepatotoxic drugs (e.g., certain antifungals, anticonvulsants) may increase the risk of liver injury. Caution is advised when using with CNS depressants like benzodiazepines or sedatives, due to additive effects on sedation. Inform your doctor of all prescription, over-the-counter, and herbal products you are taking.
Missed dose
If you miss a dose of oral naltrexone, take it as soon as you remember, unless it is almost time for your next dose. In that case, skip the missed dose and resume your regular dosing schedule. Do not double the dose to catch up. For the injectable form, contact your healthcare provider to reschedule your missed injection as soon as possible. Consistency is important for the medication’s effectiveness, so strive to adhere to the prescribed regimen.
Overdose
In the event of a suspected overdose, seek emergency medical attention immediately. Symptoms may include nausea, abdominal pain, drowsiness, or dizziness. Although naltrexone itself has a wide therapeutic index, massive overdose could potentially cause liver injury. There is no specific antidote; treatment is supportive and symptomatic. It is critical to inform medical personnel that naltrexone has been ingested, as it can complicate pain management should opioids be required for emergency care.
Storage
Store naltrexone tablets at room temperature (15-30°C or 59-86°F) in a tightly closed container, away from light, moisture, and heat. Keep out of reach of children and pets. Do not store in the bathroom. Properly dispose of any unused or expired medication as directed by your pharmacist or healthcare provider. The injectable formulation should be stored refrigerated but may be kept at room temperature for no more than 7 days prior to administration.
Disclaimer
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or medication. Never disregard professional medical advice or delay in seeking it because of something you have read here. Naltrexone is a prescription medication and should only be used under the supervision of a licensed healthcare professional.
Reviews
“After years of struggling with alcohol relapse, naltrexone gave me the stability I needed to engage meaningfully in therapy. The cravings are markedly reduced.” – James L., patient “As an addiction specialist, I have seen naltrexone help numerous patients regain control. It is most effective when combined with a strong psychosocial support system.” – Dr. Elena Rostova, MD “The injectable form offers convenience and ensures compliance, which is often a challenge in this population. A valuable tool in sustained recovery.” – Sarah T., RN, Substance Abuse Counselor “I experienced some initial nausea, but it passed within a week. Now, six months in, I am sober and rebuilding my life.” – Michael R., patient “Important progress in pharmacological treatment for AUD. Requires careful patient selection and monitoring but can be profoundly effective.” – Dr. Ben Carter, Psychiatrist